top of page

Videnskabelige studier om mRNA

Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female

Trombocytopeni

Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine

Trombocytopeni

Immune thrombocytopenia following vaccination during the COVID-19 pandemic

Trombocytopeni

Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine

Trombocytopeni

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Trombocytopeni

Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma

Trombocytopeni

Case Report Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA-1273

Trombocytopeni

Bilateral Thalamic Stroke A Case of COVID-19

Trombocytopeni

Acquired thrombotic thrombocytopenic purpura A rare disease associated with BNT162b2 vaccine

Trombocytopeni

Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination

Cardiovascular events

Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines

Cardiovascular events

Ischemic Stroke After Bivalent COVID-19 Vaccination, Self-Controlled Case Series Study

Cardiovascular events

Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination

Cardiovascular events

Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients, real-world evidence from a tertiary healthcare system

Cardiovascular events

Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination

Cardiovascular events

Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose

Cardiovascular events

Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases a study using data from the UK Biobank

Cardiovascular events

Assessment of cardiac adverse events following COVID-19 vaccination by speckle tracking echocardiography

Cardiovascular events

Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine

Cardiac

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection

Cardiac
bottom of page